Literature DB >> 11978359

Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.

Allan D Struthers1, Andrew D Morris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978359     DOI: 10.1016/S0140-6736(02)08358-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  34 in total

Review 1.  Brain natriuretic peptide: microalbuminuria for cardiac disease and diabetes?

Authors:  Per-Henrik Groop; Merlin C Thomas
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

Review 2.  Proteinaceous cysteine protease inhibitors.

Authors:  G Dubin
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

3.  Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

Authors:  G Boner; M E Cooper; K McCarroll; B M Brenner; D de Zeeuw; P R Kowey; S Shahinfar; T Dickson; R S Crow; H-H Parving
Journal:  Diabetologia       Date:  2005-08-05       Impact factor: 10.122

4.  A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.

Authors:  G J S Cooper; A A Young; G D Gamble; C J Occleshaw; A M Dissanayake; B R Cowan; D H Brunton; J R Baker; A R J Phillips; C M Frampton; S D Poppitt; R N Doughty
Journal:  Diabetologia       Date:  2009-01-27       Impact factor: 10.122

5.  Racial differences in incident heart failure among young adults.

Authors:  Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

6.  Diabetic cardiomyopathy: ongoing controversies in 2012.

Authors:  P M Seferović; I Milinković; A D Ristić; J P Seferović Mitrović; K Lalić; A Jotić; V Kanjuh; N Lalić; B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

7.  N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.

Authors:  F W Asselbergs; M P van den Berg; S J Bakker; J E Signorovitch; H L Hillege; W H van Gilst; D J van Veldhuisen
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

8.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

Review 9.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

10.  Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.

Authors:  Martin Magnusson; Stefan Jovinge; Kambiz Shahgaldi; Bo Israelsson; Leif Groop; Olle Melander
Journal:  Cardiovasc Diabetol       Date:  2010-01-18       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.